(NYSE: PFE) Pfizer's forecast annual revenue growth rate of -1.24% is not forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 6.29%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.81%.
Pfizer's revenue in 2025 is $62,785,000,000.On average, 26 Wall Street analysts forecast PFE's revenue for 2025 to be $358,893,232,097,344, with the lowest PFE revenue forecast at $339,914,340,288,768, and the highest PFE revenue forecast at $381,823,690,654,560. On average, 26 Wall Street analysts forecast PFE's revenue for 2026 to be $354,549,351,527,616, with the lowest PFE revenue forecast at $330,783,093,960,256, and the highest PFE revenue forecast at $376,990,839,235,360.
In 2027, PFE is forecast to generate $342,359,194,536,128 in revenue, with the lowest revenue forecast at $315,130,341,069,600 and the highest revenue forecast at $374,182,099,704,672.